|
1
|
Baeke F, van Etten E, Gysemans C,
Overbergh L and Mathieu C: Vitamin D signaling in immune-mediated
disorders: Evolving insights and therapeutic opportunities. Mol
Aspects Med. 29:376–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kikuta J and Ishii M: Current topics on
Vitamin D. The effects of vitamin D on the immune system. Clin
Calcium. 25:359–365. 2015.(In Japanese). PubMed/NCBI
|
|
3
|
Verstuyf A, Carmeliet G, Bouillon R and
Mathieu C: Vitamin D: A pleiotropic hormone. Kidney Int.
78:140–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Afzal S and Nordestgaard BG: Low vitamin D
and hypertension: A causal association? Lancet Diabetes Endocrinol.
2:682–684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmitz KJ, Skinner HG, Bautista LE,
Fingerlin TE, Langefeld CD, Hicks PJ, Haffner SM, Bryer-Ash M,
Wagenknecht LE, Bowden DW, et al: Association of 25-hydroxyvitamin
D with blood pressure in predominantly 25-hydroxyvitamin D
deficient Hispanic and African Americans. Am J Hypertens.
22:867–870. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Margolis KL, Ray RM, Van Horn L, Manson
JE, Allison MA, Black HR, Beresford SA, Connelly SA, Curb JD, Grimm
RH Jr, et al: Women's Health Initiative Investigators: Effect of
calcium and vitamin D supplementation on blood pressure: The
Women's Health Initiative Randomized Trial. Hypertension.
52:847–855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakashima A, Yokoyama K, Yokoo T and
Urashima M: Role of vitamin D in diabetes mellitus and chronic
kidney disease. World J Diabetes. 7:89–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin L, Grandi N, Raum E, Haug U, Arndt V
and Brenner H: Meta-analysis: Longitudinal studies of serum vitamin
D and colorectal cancer risk. Aliment Pharmacol Ther. 30:113–125.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baron JA, Barry EL, Mott LA, Rees JR,
Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, et
al: A trial of calcium and vitamin D for the prevention of
colorectal adenomas. N Engl J Med. 373:1519–1530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reimers LL, Crew KD, Bradshaw PT, Santella
RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S,
et al: Vitamin D-related gene polymorphisms, plasma
25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control.
26:187–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shui IM, Mondul AM, Lindström S, Tsilidis
KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E and
Kraft P: Breast and Prostate Cancer Cohort Consortium Group:
Circulating vitamin D, vitamin D-related genetic variation, and
risk of fatal prostate cancer in the National Cancer Institute
Breast and Prostate Cancer Cohort Consortium. Cancer.
121:1949–1956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deeb KK, Trump DL and Johnson CS: Vitamin
D signalling pathways in cancer: Potential for anticancer
therapeutics. Nat Rev Cancer. 7:684–700. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leyssens C, Verlinden L and Verstuyf A:
Antineoplastic effects of 1,25(OH)2D3 and its
analogs in breast, prostate and colorectal cancer. Endocr Relat
Cancer. 20:R31–R47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Larriba MJ, García de Herreros A and Muñoz
A: Vitamin D and the epithelial to mesenchymal transition. Stem
Cells Int. 2016:62138722016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Zhou G, Gui T, Shimokado A,
Nakanishi M, Oikawa K, Sato F and Muragaki Y: Elevated serum
1,25(OH)2-vitamin D3 level attenuates renal
tubulointerstitial fibrosis induced by unilateral ureteral
obstruction in kl/kl mice. Sci Rep. 4:65632014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ito I, Waku T, Aoki M, Abe R, Nagai Y,
Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, et al: A
nonclassical vitamin D receptor pathway suppresses renal fibrosis.
J Clin Invest. 123:4579–4594. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao P, Liu Y, Lin M, Chen YM, Shui H, Yao
T and Wu XY: Effects of 1,25-(OH)2D3 on the
expression of vitamin D receptor and angiotensin IIII in human
proximal tubular epithelial cells induced by high glucose. Chin J
Diab. 5:495–499. 2013.
|
|
18
|
Wang Y, Deb DK, Zhang Z, Sun T, Liu W,
Yoon D, Kong J, Chen Y, Chang A and Li YC: Vitamin D receptor
signaling in podocytes protects against diabetic nephropathy. J Am
Soc Nephrol. 23:1977–1986. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian Y, Lv G, Yang Y, Zhang Y, Yu R and
Zhu J, Xiao L and Zhu J: Effects of vitamin D on renal fibrosis in
diabetic nephropathy model rats. Int J Clin Exp Pathol.
7:3028–3037. 2014.PubMed/NCBI
|
|
21
|
Maquigussa E, Arnoni CP, Pereira LG and
Boim MA: Calcitriol ameliorates renal damage in a pre-established
proteinuria model. Mol Med Rep. 12:1009–1015. 2015.PubMed/NCBI
|
|
22
|
Cozzolino M, Brunini F, Capone V, Ricca F,
Kwaidri Y, Montanari E and Cusi D: Role of vitamin D in the
pathogenesis of chronic kidney disease. Recenti Prog Med.
104:33–40. 2013.(In Italian). PubMed/NCBI
|
|
23
|
Wang Y, Borchert ML and Deluca HF:
Identification of the vitamin D receptor in various cells of the
mouse kidney. Kidney Int. 81:993–1001. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong M, Gong J, Liu Y, Xiang R and Tan X:
Loss of vitamin D receptor in chronic kidney disease: A potential
mechanism linking inflammation to epithelial-to-mesenchymal
transition. Am J Physiol Renal Physiol. 303:F1107–F1115. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gurley SB and Coffman TM: The
renin-angiotensin system and diabetic nephropathy. Semin Nephrol.
27:144–152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Kong J, Deb DK, Chang A and Li
YC: Vitamin D receptor attenuates renal fibrosis by suppressing the
renin-angiotensin system. J Am Soc Nephrol. 21:966–973. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan W, Pan W, Kong J, Zheng W, Szeto FL,
Wong KE, Cohen R, Klopot A, Zhang Z and Li YC:
1,25-dihydroxyvitamin D3 suppresses renin gene
transcription by blocking the activity of the cyclic AMP response
element in the renin gene promoter. J Biol Chem. 282:29821–29830.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto
FL, Wong KE, Kong J and Li YC: 1,25-Dihydroxyvitamin D3
suppresses high glucose-induced angiotensinogen expression in
kidney cells by blocking the NF-κB pathway. Am J Physiol Renal
Physiol. 296:F1212–F1218. 2009. View Article : Google Scholar : PubMed/NCBI
|
